5-([4-(benzoylamino)phenyl]aminosulfonyl)-2-chlorobenzoic acid
95%
- Product Code: 141781
CAS:
423728-81-8
| Molecular Weight: | 430.8615 g./mol | Molecular Formula: | C₂₀H₁₅ClN₂O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | 1.528±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C |
Product Description:
Used primarily as an intermediate in the synthesis of sulfa-based pharmaceutical compounds, particularly in the development of carbonic anhydrase inhibitors. These inhibitors are relevant in treating glaucoma, epilepsy, and certain types of edema. The compound's structure allows for selective binding to enzyme active sites, enhancing its pharmacological utility. It is also employed in research settings to design new sulfonamide derivatives with improved bioavailability and target specificity.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿48,000.00 |
+
-
|
| 250mg | 10-20 days | ฿80,000.00 |
+
-
|
5-([4-(benzoylamino)phenyl]aminosulfonyl)-2-chlorobenzoic acid
Used primarily as an intermediate in the synthesis of sulfa-based pharmaceutical compounds, particularly in the development of carbonic anhydrase inhibitors. These inhibitors are relevant in treating glaucoma, epilepsy, and certain types of edema. The compound's structure allows for selective binding to enzyme active sites, enhancing its pharmacological utility. It is also employed in research settings to design new sulfonamide derivatives with improved bioavailability and target specificity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :